| 标题 |
EFFICACY OF DEUCRAVACITINIB, A FIRST-IN- CLASS, ORAL, SELECTIVE, ALLOSTERIC TYROSINE KINASE 2 INHIBITOR, IN MUSCULOSKELETAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS: A SUBANALYSIS OF THE PHASE 2 PAISLEY STUDY |
| 网址 | |
| DOI |
10.1136/annrheumdis-2024-eular.1522
doi
|
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)